Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02611323
Title A Study of Obinutuzumab, Rituximab, Polatuzumab Vedotin, and Venetoclax in Relapsed or Refractory Follicular Lymphoma (FL) or Diffuse Large B-Cell Lymphoma (DLBCL)
Recruitment Active, not recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Hoffmann-La Roche
Indications

diffuse large B-cell lymphoma

follicular lymphoma

B-cell lymphoma

non-Hodgkin lymphoma

Therapies

Polatuzumab vedotin-piiq + Rituximab + Venetoclax

Obinutuzumab + Polatuzumab vedotin-piiq + Venetoclax

Age Groups: senior | adult
Covered Countries USA | ITA

Facility Status City State Zip Country Details
University of Arizona Cancer Center Tucson Arizona 85719 United States Details
Yale Cancer Center New Haven Connecticut 06520 United States Details
Memorial Healthcare System Pembroke Florida 33028 United States Details
Emory Univ Winship Cancer Inst Atlanta Georgia 30322 United States Details
University of Louisville Hospital; The James Graham Brown Cancer Center Louisville Kentucky 40202 United States Details
University of Michigan Ann Arbor Michigan 48109-0934 United States Details
Rutgers Cancer Institute of New Jersey New Brunswick New Jersey 08901 United States Details
Roswell Park Cancer Inst. Buffalo New York 14263 United States Details
Fox Chase Cancer Center Philadelphia Pennsylvania 19111 United States Details
Scott and White Temple Texas 76508 United States Details
Royal North Shore Hospital; Haematology Department St. Leonards New South Wales 2065 Australia Details
Calvary Mater Newcastle Waratah New South Wales 2298 Australia Details
Princess Alexandra Hospital Woolloongabba Queensland 4102 Australia Details
The Queen Elizabeth Hospital Adelaide South Australia 5011 Australia Details
Royal Hobart Hospital Hobart Tasmania 7000 Australia Details
Peter MacCallum Cancer Center North Melbourne Victoria 3051 Australia Details
Papa Giovanni Hospital XXIII Bergamo Emilia-Romagna 24127 Italy Details
Istituto Scientifico Romagnolo Per Lo Studio e La Cura Dei Tumori Meldola Emilia-Romagna 47014 Italy Details
UO Ematologia, Ospedale S.Maria delle Croci Ravenna Emilia-Romagna 48121 Italy Details
Ospedale Infermi U.O. Ematologia Rimini Emilia-Romagna 47923 Italy Details
Fondazione IRCCS Istituto Nazionale dei Tumori Milano Lombardia 20133 Italy Details
SCDU Ematologia Novara Piemonte 28100 Italy Details
A.O.U. Citta' Della Salute E Della Scienza-P.O. Molinette;S.C. Ematologia Torino Piemonte 10126 Italy Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field